Breath test may unlock better IBS treatment for diarrhea patients
NCT ID NCT03729271
First seen Jan 12, 2026 · Last updated May 15, 2026 · Updated 18 times
Summary
This study looked at whether a simple breath test can help identify which people with diarrhea-predominant irritable bowel syndrome (IBS-D) are more likely to get relief from the antibiotic rifaximin. 148 adults with IBS-D took the breath test and then received rifaximin treatment. Researchers tracked their abdominal pain and stool consistency to see if the breath test results matched who improved. The goal is to make IBS-D treatment more personalized and effective.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IRRITABLE BOWEL SYNDROME are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
University of Michigan
Ann Arbor, Michigan, 48109, United States
Conditions
Explore the condition pages connected to this study.